Green Street Acquires IJGlobal, Leading Provider of Global Infrastructure Data, News and Events
--Green Street Continues to Grow, Expanding Its Global Product Suite with Comprehensive and Granular Property-Level Data, News and Events in Infrastructure--
Green Street, the preeminent provider of commercial real estate intelligence and analytics in the U.S., Canada, and Europe, has acquired IJGlobal, part of the Delinian Group – leading provider of data, news, and events covering all aspects of the international infrastructure and energy finance industry. IJGlobal is Green Street’s fifth acquisition since 2020, and it follows the May 2024 acquisition of Locatus – a Netherlands based provider of independently sourced retail data and analytics in the Benelux region.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240905220824/en/
Green Street, the leading provider of Commercial Real Estate intelligence, acquires IJGlobal, a comprehensive infrastructure company that includes a data platform, global news, and industry leading events/awards. (Graphic: Business Wire)
“IJGlobal is committed to being the market’s most comprehensive source of infrastructure intelligence with a global presence across North America, South America, Asia, Africa, Europe, and Australia, and its great talent and reputation for providing top-quality objective insights make a strong fit for Green Street. IJGlobal’s deep coverage of infrastructure accelerates our commitment to expanding property-level data and analytics across sectors and geographies and dramatically strengthens our increasing coverage of the infrastructure sector on a global basis,” said Jeffry Stuek Jr., Green Street’s Chief Executive Officer. “We are excited to integrate these capabilities to provide our clients with industry leading insight.”
For more than 17 years, IJGlobal has been delivering the market’s most comprehensive infrastructure intelligence through a database of 55,000+ transactions, 41,000+ assets, and 3,400+ funds. Their team of experts publishes more than 40 stories a day to inform financial structure, policy, pricing, and key market players, helping customers manage risk and identify leads. They also track and celebrate key infrastructure and energy industry achievements through a multitude of annual Events and Awards that connect the market and accelerate deals. IJGlobal services a wide range of customer segments including financial advisers and lenders, legal advisers, Development Finance Institutions (DFIs), institutional investors, project sponsors, and infrastructure funds, among others.
Commenting on the sale, Andrew Pinder, Chief Executive Officer of Delinian, said, “In line with our continued strategy of ‘invest, grow and divest’ for each of our portfolio companies, we are delighted that Green Street represents such a great fit for IJGlobal. It offers the business an exciting opportunity to further expand its depth and reach of infrastructure insights, data and events, with access to resources and expertise within a broader property-level data and analytics ecosystem. We wish the IJGlobal team every success as they now transition to Green Street.”
For more information, visit the IJGlobal website or Green Street website.
About Green Street
Green Street is the preeminent provider of actionable commercial real estate research, news, data, analytics, and advisory services in the U.S., Canada, and Europe. For nearly 40 years, Green Street has delivered unparalleled intelligence and trusted data on the public and private real estate markets, helping investors, banks, lenders, and other industry participants optimize investment and strategic decisions. The firm delivers exclusive market information, conclusion-driven insights, and predictive analytics through a SaaS platform. To learn more, please visit https://www.greenstreet.com.
About IJGlobal
IJGlobal is a single source of data, intelligence and analysis covering all aspects of the international infrastructure and energy finance industry. IJGlobal delivers news, transaction and investor/fund data, and events for global infrastructure to market participants worldwide, and through a comprehensive database that encompasses all infrastructure transaction participants, exclusive daily news, live League Table rankings, and more. IJGlobal is headquartered in London and was founded in 1997. For more information, please visit https://hub.ijglobal.com/.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240905220824/en/
Contacts
Green Street Media
Green Street Media
media@greenstreet.com
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Deciphera Announces Oral Presentation of Positive Topline Results from Phase 2a Study of Sapablursen in Polycythemia Vera at the 67th American Society of Hematology (ASH) Annual Meeting6.12.2025 15:30:00 CET | Press release
Results from Phase 2a IMPRSSION study demonstrate sapablursen significantly reduced phlebotomy rate, controlled hematocrit and increased serum hepcidin Sapablursen was generally safe and well tolerated Results support further development of sapablursen in a Phase 3 study Deciphera Pharmaceuticals, a member of Ono Pharmaceutical Co., Ltd. (Headquarters: Osaka, Japan; President and COO: Toichi Takino; “Ono”), today announced the oral presentation of positive results from the Phase 2a IMPRSSION study of sapablursen in patients with polycythemia vera (PV) at the 67th American Society of Hematology (ASH) Annual Meeting, taking place December 6-9, 2025, in Orlando, FL. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251206361611/en/ The results were presented by Ionis Pharmaceuticals, who discovered and developed sapablursen and conducted the IMPRSSION study. In March 2025, Ionis and Ono entered into a license agreement in which On
Protagonist and Takeda Present Longer-Term Data at ASH 2025 Showing Rusfertide Delivers Durable Response and Hematocrit Control in Polycythemia Vera6.12.2025 15:30:00 CET | Press release
52-Week Results from the Phase 3 VERIFY Study of Rusfertide Demonstrated Sustained Hematocrit Control and Response, Defined by Absence of Phlebotomy Eligibility, with No New Safety SignalsThese Data Build on Positive 32-Week Primary Analysis from VERIFY, Which Met its Primary Efficacy Endpoint and All Four Key Secondary EndpointsPatients Crossing Over from Placebo to Rusfertide at 32 Weeks Achieved a Similar Response Rate to Those Initially Randomized to Rusfertide, with 77.9% Achieving Absence of Phlebotomy Eligibility Between Weeks 40-52Four-Year Results from the Combined REVIVE and Long-Term Extension THRIVE Study Demonstrated a 13-Fold Reduction in Annual Rate of Phlebotomies from Baseline Protagonist Therapeutics, Inc. (“Protagonist”) (NASDAQ:PTGX) and Takeda (TSE:4502/NYSE:TAK) announce that new 52-week results from the pivotal Phase 3 VERIFY study evaluating rusfertide in patients with polycythemia vera (PV) will be presented in an oral presentation at the 67th American Society
Vertex Presents New Data on CASGEVY®, Including First-Ever Data in Children Ages 5-11 Years, at the American Society of Hematology Annual Meeting and Announces Plan for Global Regulatory Submissions6.12.2025 13:01:00 CET | Press release
- Data from pivotal studies of CASGEVY in children ages 5-11 years with severe sickle cell disease or transfusion-dependent beta thalassemia demonstrates the transformative potential of the therapy in younger patients -- Efficacy and safety data in children 5-11 years are consistent with the durable and positive benefit/risk profile established from clinical studies in patients 12 years of age and older -- Vertex expects to initiate global regulatory submissions for CASGEVY in children 5-11 years in 1H 2026 - Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced data from multiple studies demonstrating the clinical benefits of CASGEVY® (exagamglogene autotemcel) in people ages 5 years and older living with severe sickle cell disease (SCD) or transfusion-dependent beta thalassemia (TDT). The results, including the first presentation of clinical data from pivotal studies in children ages 5-11 years, and longer-term data from the pivotal studies of people with severe SCD and
Leading Global Scientists Gather at Tengchong Scientists Forum to Explore Innovative Pathways in Frontier Technologies6.12.2025 12:31:00 CET | Press release
The 2025 Tengchong Scientists Forum opened on Saturday in southwest China’s Yunnan Province, convening leading scientists and academic figures to examine innovation across frontier fields including artificial intelligence, biodiversity and quantum technology. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251205499197/en/ Opening ceremony of Tengchong Scientists Forum on 6th December, 2025 Notable participants include Nobel Physics laureate Konstantin Novoselov, Fields Medalist Efim Zelmanov and Turing Award winner Andrew Chi-Chih Yao, who join 127 academicians, 77 university presidents from China and abroad, over 400 scholars and more than 600 entrepreneurs and financiers. The gathering aims to deepen collaboration between cutting-edge research and industrial development. Under the theme “Science · AI changing the World,” the forum features ten sub-forums, academic sessions and thematic events supporting major cooperation p
Lattice Wins 2025 Global Semiconductor Alliance Award6.12.2025 00:49:00 CET | Press release
‒ Named Most Respected Public Semiconductor Company Achieving $100 Million to $500 Million in Annual Sales ‒ Lattice Semiconductor (NASDAQ: LSCC), the low power programmable leader, today announced that it was selected as ‘Most Respected Public Semiconductor Company’ at the 2025 Global Semiconductor Alliance (GSA) Awards. The GSA awards recognize companies that have demonstrated excellence through their success, vision, strategy, and future opportunities in the industry as determined by votes from GSA members. “We are honored to be recognized by the Global Semiconductor Alliance and our peers as one of 2025’s most respected public semiconductor companies. This recognition reflects the dedication of the Lattice team and the trust of our customers, partners, suppliers, and investors. Looking ahead, we remain laser-focused on driving innovation and strengthening our role as the trusted low power programmable leader for semiconductor and system solutions,” said Ford Tamer, Chief Executive
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom